[HTML][HTML] Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Background Understanding the level and characteristics of protection from past SARS-CoV-
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …
Severity and outcomes of SARS-CoV-2 reinfection compared with primary infection: a systematic review and meta-analysis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection has brought
new challenges to the global prevention and control of coronavirus disease 2019 (COVID …
new challenges to the global prevention and control of coronavirus disease 2019 (COVID …
Immune imprinting and protection against repeat reinfection with SARS-CoV-2
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2 | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
Background Long-term effectiveness of COVID-19 mRNA boosters in populations with
different previous infection histories and clinical vulnerability profiles is inadequately …
different previous infection histories and clinical vulnerability profiles is inadequately …
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
R Zonozi, LC Walters, A Shulkin, V Naranbhai… - Science translational …, 2023 - science.org
Individuals with primary and pharmacologic B cell deficiencies have high rates of severe
disease and mortality from coronavirus disease 2019 (COVID-19), but the immune …
disease and mortality from coronavirus disease 2019 (COVID-19), but the immune …
Protection against reinfection with the omicron BA. 2.75 subvariant
H Chemaitelly, P Tang, P Coyle… - … England Journal of …, 2023 - Mass Medical Soc
Effect of Previous SARS-CoV-2 Infection against BA. 2.75 Infection A test-negative, case–
control study in Qatar showed that previous infection with pre-omicron strains of SARS-CoV …
control study in Qatar showed that previous infection with pre-omicron strains of SARS-CoV …
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA. 4, BA. 5, and XBB reinfections in Singapore: a …
Background Despite a large proportion of the population having been vaccinated and
infected, Singapore had SARS-CoV-2 waves driven by the BA. 5 and XBB sublineages of …
infected, Singapore had SARS-CoV-2 waves driven by the BA. 5 and XBB sublineages of …
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
U Marking, O Bladh, S Havervall… - The Lancet Infectious …, 2023 - thelancet.com
Mucosal immunity has a pivotal role in protection from respiratory viral infections. 1 The
current authors have showed substantial protection from omicron infection by high …
current authors have showed substantial protection from omicron infection by high …
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Summary Background Protection against SARS-CoV-2 symptomatic infection and severe
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …
[PDF][PDF] COVID-19: Epidemiology, virology, and prevention
K McIntosh, MS Hirsch, A Bloom - UpToDate. Available online …, 2021 - hoiyhoctphcm.org.vn
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …